Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ayez, Ninos
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial. [electronic resource] - BMC cancer Mar 2015 - 180 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1471-2407
10.1186/s12885-015-1199-8 doi
Adult
Aged
Colorectal Neoplasms--drug therapy
Combined Modality Therapy
Digestive System Surgical Procedures
Disease-Free Survival
Female
Humans
Liver Neoplasms--drug therapy
Male
Middle Aged
Neoadjuvant Therapy
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Risk Factors
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial. [electronic resource] - BMC cancer Mar 2015 - 180 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1471-2407
10.1186/s12885-015-1199-8 doi
Adult
Aged
Colorectal Neoplasms--drug therapy
Combined Modality Therapy
Digestive System Surgical Procedures
Disease-Free Survival
Female
Humans
Liver Neoplasms--drug therapy
Male
Middle Aged
Neoadjuvant Therapy
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Risk Factors